Case of post‐progression prolongation of survival after cessation of pembrolizumab in advanced non‐small‐cell lung cancer
| Field | Value | Language |
| dc.contributor.author | Liu, Jia | en |
| dc.contributor.author | Wong, Kirby | en |
| dc.contributor.author | Patanjali, Nitya | en |
| dc.contributor.author | Boyer, Michael | en |
| dc.contributor.author | Kao, Steven | en |
| dc.date.accessioned | 2020-07-09 | |
| dc.date.available | 2020-07-09 | |
| dc.date.issued | 2020 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/22771 | |
| dc.language.iso | en | en |
| dc.rights | Other | |
| dc.subject | COVID-19 | en |
| dc.subject | Coronavirus | en |
| dc.title | Case of post‐progression prolongation of survival after cessation of pembrolizumab in advanced non‐small‐cell lung cancer | en |
| dc.type | Article | en |
| dc.identifier.doi | 10.1111/imj.14852 | |
| usyd.faculty | Faculty of Medicine and Health, Sydney Medical School | en |
Associated file/s
There are no files associated with this item.
Associated collections